Skip to main content

Advertisement

Log in

Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

To investigate the recent Japanese prevalence of thyroid cancer and its characteristics in familial adenomatous polyposis (FAP) patients, through the development of surveillance programs.

Methods

The subjects of this study were 282 (93.1%) FAP patients for whom information on thyroid cancer was available, from among 303 patients registered in “the Retrospective Cohort Study of Familial Adenomatous Polyposis in Japan” database. We evaluated the prevalence and risk factors for thyroid cancer and integrated and/or compared our findings with those of previous reports, using a systematic review, including a meta-analysis.

Results

Thyroid cancer was diagnosed in 16 women (11.4%) and 2 men (1.4%), at 17–41 years and 39–57 years of age, respectively. The prevalence of thyroid cancer was 6.4%, with a female-to-male ratio of 8:1, which is comparable to reports from other countries. A young age of < 33 years at the FAP diagnosis and female gender were identified as independent risk factors for thyroid cancer.

Conclusions

FAP-associated thyroid cancer predominantly affects young women, both in Japan and other countries. Since FAP is generally diagnosed when patients are in their 20 s or older, regular screening for thyroid cancer is recommended for all FAP patients, but especially women, from their early 20 s.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991;253:665–9.

    Article  CAS  Google Scholar 

  2. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science. 1991;253:661–5.

    Article  CAS  Google Scholar 

  3. Bulow S. Results of national registration of familial adenomatous polyposis. Gut. 2003;52:742–6.

    Article  CAS  Google Scholar 

  4. Burn J, Chapman P, Delhanty J, Wood C, Lalloo F, Cachon-Gonzalez MB, et al. The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations. J Med Genet. 1991;28:289–96.

    Article  CAS  Google Scholar 

  5. Jarvinen HJ. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut. 1992;33:357–60.

    Article  CAS  Google Scholar 

  6. Bulow S, Faurschou Nielsen T, Bülow C, Bisgaard ML, Karlsen L, Moesgaard F. The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int J Colorectal Dis. 1996;11:88–91.

    Article  CAS  Google Scholar 

  7. HJR B. Familial polyposis coli. Baltimore: Johns Hopkins University Press; 1975.

    Google Scholar 

  8. Iwama T, Tamura K, Morita T, Hirai T, Hasegawa H, Koizumi K, et al. A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol. 2004;9:308–16. https://doi.org/10.1007/s10147-004-0414-4.

    Article  PubMed  Google Scholar 

  9. Nieuwenhuis MH, De VTotN Cappel, Botma W, Nagengast A, Kleibeuker FM, Mathus-Vliegen JH. EM, et al. Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008;6:215–9. https://doi.org/10.1016/j.cgh.2007.11.011.

    Article  PubMed  Google Scholar 

  10. Maehata Y, Esaki M, Hirahashi M, Kitazono T, Matsumoto T. Duodenal adenomatosis in Japanese patients with familial adenomatous polyposis. Dig Endosc. 2014;26(Suppl 2):30–4. https://doi.org/10.1111/den.12255.

    Article  PubMed  Google Scholar 

  11. Plail RO, Bussey HJ, Glazer G, Thomson JP. Adenomatous polyposis: an association with carcinoma of the thyroid. Br J Surg. 1987;74:377–80.

    Article  CAS  Google Scholar 

  12. Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut. 1993;34:1394–6.

    Article  CAS  Google Scholar 

  13. Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg. 1993;217:101–8.

    Article  CAS  Google Scholar 

  14. Bulow C, Bulow S. Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J Colorectal Dis. 1997;12:240–2.

    Article  CAS  Google Scholar 

  15. Truta B, Allen BA, Conrad PG, Kim YS, Berk T, Gallinger S, et al. Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma. Fam Cancer. 2003;2:95–9.

    Article  CAS  Google Scholar 

  16. Harach HR, Williams GT, Williams ED. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology. 1994;25:549–61.

    Article  CAS  Google Scholar 

  17. Cameselle-Teijeiro J, Chan JK. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol. 1999;12:400–11.

    CAS  PubMed  Google Scholar 

  18. Soravia C, Sugg SL, Berk T, Mitri A, Cheng H, Gallinger S, et al. Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am J Pathol. 1999;154:127–35. https://doi.org/10.1016/s0002-9440(10)65259-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Bulow S, Holm NV, Mellemgaard A. Papillary thyroid carcinoma in Danish patients with familial adenomatous polyposis. Int J Colorectal Dis. 1988;3:29–31.

    Article  CAS  Google Scholar 

  20. Perrier ND, van Heerden JA, Goellner JR, Williams ED, Gharib H, Marchesa P, et al. Thyroid cancer in patients with familial adenomatous polyposis. World J Surg. 1998; 22:738–42 (discussion 743).

    Article  CAS  Google Scholar 

  21. van der Linde K, Vasen HF, van Vliet AC. Occurrence of thyroid carcinoma in Dutch patients with familial adenomatous polyposis. An epidemiological study and report of new cases. Eur J Gastroenterol Hepatol. 1998;10:777–81.

    Article  Google Scholar 

  22. Herraiz M, Barbesino G, Faquin W, Chan-Smutko G, Patel D, Shannon KM, et al. Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol. 2007;5:367–73. https://doi.org/10.1016/j.cgh.2006.10.019.

    Article  PubMed  Google Scholar 

  23. Jarrar AM, Milas M, Mitchell J, Laguardia L, O’Malley M, Berber E, et al. Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg. 2011;253:515–21. https://doi.org/10.1097/SLA.0b013e3181fcba8a.

    Article  PubMed  Google Scholar 

  24. Steinhagen E, Guillem JG, Chang G, Salo-Mullen EE, Shia J, Fish S, et al. The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized. Clin Colorectal Cancer. 2012;11:304–8. https://doi.org/10.1016/j.clcc.2012.01.006.

    Article  PubMed  Google Scholar 

  25. Steinhagen E, Hui VW, Levy RA, Markowitz AJ, Fish S, Wong RJ, et al. Results of a prospective thyroid ultrasound screening program in adenomatous polyposis patients. Am J Surg. 2014;208:764–9. https://doi.org/10.1016/j.amjsurg.2014.03.012.

    Article  PubMed  Google Scholar 

  26. Hizawa K, Iida M, Aoyagi K, Yao T, Fujishima M. Thyroid neoplasia and familial adenomatous polyposis/Gardner’s syndrome. J Gastroenterol. 1997;32:196–9.

    Article  CAS  Google Scholar 

  27. Ueno H, Kobayashi H, Konishi T, Ishida F, Yamaguchi T, Hinoi T, et al. Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan. Int J Clin Oncol. 2016;21:713–22. https://doi.org/10.1007/s10147-016-0953-5.

    Article  CAS  PubMed  Google Scholar 

  28. Ho JW, Chu KM, Tse CW, Yuen ST. Phenotype and management of patients with familial adenomatous polyposis in Hong Kong: perspective of the Hereditary Gastrointestinal Cancer Registry. Hong Kong Med J. 2002;8:342–7.

    CAS  PubMed  Google Scholar 

  29. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–7. https://doi.org/10.1001/jama.295.18.2164.

    Article  CAS  PubMed  Google Scholar 

  30. Saika K, Matsuda T, Sobue T. Incidence rate of thyroid cancer by histological type in Japan. Jpn J Clin Oncol. 2014;44:1131–2. https://doi.org/10.1093/jjco/hyu179.

    Article  PubMed  Google Scholar 

  31. Matsuda A, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H, et al. Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2014;44:388–96. https://doi.org/10.1093/jjco/hyu003.

    Article  PubMed  Google Scholar 

  32. Kennedy RD, Potter DD, Moir CR, El-Youssef M. The natural history of familial adenomatous polyposis syndrome: a 24 year review of a single center experience in screening, diagnosis, and outcomes. J Pediatr Surg. 2014;49:82–6. https://doi.org/10.1016/j.jpedsurg.2013.09.033.

    Article  PubMed  Google Scholar 

  33. Uchino S, Ishikawa H, Miyauchi A, Hirokawa M, Noguchi S, Ushiama M, et al. Age- and gender-specific risk of thyroid cancer in patients with familial adenomatous polyposis. J Clin Endocrinol Metab. 2016;101:4611–7.

    Article  CAS  Google Scholar 

  34. Septer S, Slowik V, Morgan R, Dai H, Attard T. Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals. Hered Cancer Clin Pract. 2013;11:13. https://doi.org/10.1186/1897-4287-11-13.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Nieuwenhuis MH, Bülow S, Bjork J, Jarvinen HJ, Bülow C, Bisgaard ML, et al. Genotype predicting phenotype in familial adenomatous polyposis: a practical application to the choice of surgery. Dis Colon Rectum. 2009;52:1259–63. https://doi.org/10.1007/DCR.0b013e3181a0d33b.

    Article  PubMed  Google Scholar 

  36. Groen EJ, Roos A, Muntinghe FL, Enting RH, de Vries J, Kleibeuker JH, et al. Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol. 2008;15:2439–50. https://doi.org/10.1245/s10434-008-9981-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We appreciate the support with our statistical analyses, given by Minoru Hattori, Advanced Medical Skills Training Center, Hiroshima University, and we thank the Japanese Society for Cancer of Colon and Rectum (JSCCR) for their cooperation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takao Hinoi.

Ethics declarations

Conflict of interest

We have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sada, H., Hinoi, T., Ueno, H. et al. Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review. Surg Today 49, 72–81 (2019). https://doi.org/10.1007/s00595-018-1710-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-018-1710-3

Keywords

Navigation